These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 572998)

  • 1. The binding of diiodosalicylate and flufenamate to the plasma antiactivator: analysis of chemical fibrinolysis.
    Nanninga LB
    Thromb Haemost; 1979 Apr; 41(2):357-64. PubMed ID: 572998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and properties of an antiactivator fraction from bovine serum.
    Nanninga LB; Guest MM
    Thromb Haemost; 1979 Oct; 42(3):855-63. PubMed ID: 92070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
    Nanninga LB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood fibrinolytic system in rana tigrina.
    Srivastava VM; Dube B; Dube RK; Agarwal GP; Ahmad N
    Thromb Haemost; 1981 Jun; 45(3):252-4. PubMed ID: 7281104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
    Christensen U; Holmberg L; Bladh B; Astedt B
    Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinolytic action of flufenamate and its influence on plasminogen binding to fibrin.
    Chevallet-Prandini MH; Chapel A; Suscillon M
    Thromb Res; 1985 Jun; 38(5):481-9. PubMed ID: 4012673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.
    Miles LA; Plow EF
    Thromb Haemost; 1987 Oct; 58(3):936-42. PubMed ID: 2829380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor.
    Loskutoff DJ; Ny T; Sawdey M; Lawrence D
    J Cell Biochem; 1986; 32(4):273-80. PubMed ID: 3100541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolytic activity of acyl-urokinase].
    Stürzebecher J; Kroneck I; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of fibrinolytic activity in bovine plasma by the combined effects of chloroform and dextran sulphate.
    Jenks RL; Kluft C; Astrup T
    Haemostasis; 1981; 10(2):108-18. PubMed ID: 6161866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
    Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
    Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
    Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.